THC
Tenet Healthcare Corporation · Healthcare · Medical - Care Facilities
Señales de momentum (gestores comparables):
amplitud de titulares +5.9% ·
flujo de acciones +7.8% ·
nuevas posiciones netas +5.6%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 138 | +1 | 64.57M | $12.08B | +9 | −8 |
| Q1 2026 | 140 | -6 | 67.35M | $12.71B | +5 | −12 |
| Q4 2025 | 146 | 0 | 74.52M | $14.80B | +2 | −1 |
| Q3 2025 | 23 | 0 | 47.80M | $9.71B | — | −1 |
| Q2 2025 | 21 | 0 | 49.65M | $8.73B | +1 | −1 |
| Q1 2025 | 18 | +1 | 24.64M | $3.31B | +1 | — |
| Q4 2024 | 17 | -2 | 22.85M | $2.89B | — | −2 |
| Q3 2024 | 18 | 0 | 21.19M | $3.52B | — | — |
| Q2 2024 | 18 | — | 23.95M | $3.19B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 7.60M | +6.5% | $1.02B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 7.60M | +6.5% | $1.02B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | Glenview Capital ✦ | 3.39M | +19.7% | $456.61M | 11.3% | ▲ Add | 4 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (pasivo) | 3.02M | +1.0% | $406.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 2.20M | +4.0% | $296.56M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 2.20M | +4.0% | $296.56M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.87M | +643.2% | $251.05M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 8 | Norges Bank ✦ (pasivo) | 1.45M | -4.4% | $194.42M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Millennium Management ✦ | 1.24M | +201.2% | $166.25M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 1.19M | -33.0% | $159.89M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 903.27K | +3.6% | $118.86M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 903.27K | +3.6% | $118.86M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 903.27K | +3.6% | $118.86M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 903.27K | +3.6% | $118.86M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 903.27K | +3.6% | $118.86M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 728.26K | -28.4% | $97.95M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 728.26K | -28.4% | $97.95M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 469.53K | +111.3% | $63.15M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 199.98K | -50.9% | $26.90M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 20 | Marshall Wace ✦ | 193.50K | -61.3% | $26.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 108.58K | Nuevo | $14.60M | 0.0% | New | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 35.26K | -92.0% | $4.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 25.85K | -90.0% | $3.48M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 21.30K | -81.3% | $2.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Harris Associates (Oakmark) ✦ | 2.40K | -29.4% | $322,800 | 0.0% | ▼ Trim | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Point72 Asset Management | $14.60M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 686 tenedores, 81.68M acciones, $13.63B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 2.50K acc. · $652,075
Director · 4.92K acc. · $1.30M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología